newsfilter
← Latest News
GlobeNewswire·

ChemoCentryx Announces Abstracts at June Rheumatology, Oncology and Nephrology Conferences

SAN CARLOS, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (NASDAQ:CCXI), today announced upcoming abstract presentations at three key medical conferences taking place in June, which highlight TAVNEOS® (avacopan), an orally administered